Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation.

Nanomaterials (Basel) · 2022 · PMC8838925 · PMID 35159859

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Over recent years, there has been a clear trend of translating the results from in vitro and in silico studies into in vivo for hazard and risk assessment of NPs (also called “in vitro to in vivo extrapolation”, IVIVE) [ 13 , 14 , 15 , 16 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.